Vanda Pharmaceuticals Inc. (LON:0LKB)
London flag London · Delayed Price · Currency is GBP · Price in USD
4.509
0.00 (0.00%)
At close: Jun 16, 2025

Vanda Pharmaceuticals Revenue

Vanda Pharmaceuticals had revenue of $50.04M USD in the quarter ending March 31, 2025, with 5.43% growth. This brings the company's revenue in the last twelve months to $201.35M, up 13.37% year-over-year. In the year 2024, Vanda Pharmaceuticals had annual revenue of $198.77M with 3.18% growth.

Revenue (ttm)
$201.35M
Revenue Growth
+13.37%
P/S Ratio
1.27
Revenue / Employee
$547.15K
Employees
368
Market Cap
197.32M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024198.77M6.13M3.18%
Dec 31, 2023192.64M-61.74M-24.27%
Dec 31, 2022254.38M-14.30M-5.32%
Dec 31, 2021268.68M20.51M8.27%
Dec 31, 2020248.17M20.98M9.23%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
Shell 217.54B
HSBC Holdings 44.89B
Unilever 50.25B
British American Tobacco p.l.c. 25.87B
Rolls-Royce Holdings 18.91B
Rio Tinto Group 42.86B
RELX PLC 9.43B
Revenue Rankings